With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
The International Initiative for Impact Evaluation (3ie) has announced that Emmanuel (Manny) Jimenez will be the organization’s new Executive Director starting in early 2015. The selection of Jimenez represents a key transition for 3ie, which has moved quickly from start-up to maturity in just six years.
I never cease to be astonished by the amount of energy people put into claiming that Randomized Control Trials (RCTs) are the be-all and end-all of impact evaluation methods; nor at the energy people put into claiming that RCTs are marginal, costly, and a waste of time.
The spread of knowledge and ideas should help close the gap between rich countries and poor. That’s why technology transfer is one of the seven components of CGD’s Commitment to Development Index (CDI).
Proponents of the use of randomized controlled trials (RCTs) in impact evaluation and development research often point out the close link between these trials and their clinical counterparts in the world of medical research.
I have always chafed at the idea of “capacity building” – a donor fallback in developing countries whenever progress on a donor-financed project is slow. Too much of what donors mean by capacity building has turned out to be training sessions, workshops, and nice trips of mid-level technical staff from low-income countries to Paris, London and Washington.